Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody

SM03, a chimeric antibody that targets the B-cell restricted antigen CD22, is currently being clinically evaluated for the treatment of lymphomas and other autoimmune diseases in China. SM03 binding to surface CD22 leads to rapid internalization, making the development of an appropriate cell-based b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:MAbs
Hlavní autoři: Leung, Shui-on, Gao, Kai, Wang, Guang Yu, Cheung, Benny Ka-wa, Lee, Kwan-yeung, Zhao, Qi, Cheung, Wing-Tai, Wang, Jun Zhi
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2014
Témata:
Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623522/
https://ncbi.nlm.nih.gov/pubmed/25427174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.985519
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky